Susan Graf

Director/Board Member at CG ONCOLOGY, INC.

Net worth: - $ as of 31/08/2026

53 year

63 connections

Health Technology

Consumer Services

Health Services

Profile

Susan E.
Graf is currently Director at Kaleo, Inc. since 2021, Independent Director at CG Oncology, Inc. since 2023, and Independent Director at Aardvark Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Akamara Therapeutics, Inc. from 2019 to 2021, Independent Chairman at Finch Therapeutics Group, Inc. from 2022 to 2024, Director at Vitrisa Therapeutics, Inc., Vice President-Corporate Development & Strategy at NPS Pharmaceuticals, Inc. from 2013 to 2015, and Chief Financial & Business Officer at Epizyme, Inc. from 2016 to 2018.
Education includes undergraduate studies at Purdue University and an MBA from The Leonard N Stern School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CG ONCOLOGY, INC. -.--%	04/06/2026	0 ( -.--% )	- $	31/08/2026
AARDVARK THERAPEUTICS, INC. -.--%	14/08/2026	0 ( -.--% )	- $	31/08/2026

Susan Graf active positions

Companies	Position	Start
CG ONCOLOGY, INC.	Director/Board Member	20/11/2023
AARDVARK THERAPEUTICS, INC.	Director/Board Member	01/11/2024
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Director/Board Member	01/12/2021

All active positions of Susan Graf

Former positions of Susan Graf

Companies	Position	End
FINCH THERAPEUTICS GROUP, INC.	Chairman	01/03/2024
Akamara Therapeutics, Inc. Akamara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Chief Executive Officer	01/05/2021
EPIZYME, INC.	Director of Finance/CFO	30/09/2018
NPS PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2015
Vitrisa Therapeutics, Inc. Vitrisa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	-

See the detail of Susan Graf's experience

Training of Susan Graf

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susan Graf's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
NPS Pharmaceuticals, Inc. NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases	Health Technology
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Health Technology
Purdue University Purdue University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers	Health Technology
CG Oncology, Inc. CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic	Health Technology
The Leonard N Stern School of Business The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services	Health Services
Vitrisa Therapeutics, Inc. Vitrisa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Aardvark Therapeutics, Inc. Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases	Health Technology
Akamara Therapeutics, Inc. Akamara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology